Addressing Transgender Erasure in HIV Clinical Trials: The Scorecard for Transgender and Gender-Diverse Inclusion.
We sought to offer a structured framework for evaluating transgender and gender-diverse (TGD) inclusion in HIV clinical trials, with actionable criteria for trial design and conduct, and to quantify and characterize TGD inclusion in pivotal HIV studies as supporting evidence of the need for this fra...
| Publicado en: | American Journal of Public Health Vol. 115; no. 10; pp. 1621 - 1631 |
|---|---|
| Autores principales: | , |
| Formato: | Artículo |
| Publicado: |
American Public Health Association
Oct2025
|
| Materias: | |
| Acceso en línea: | Ver este registro en EBSCOhost |